VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

Papillary thyroid carcinoma (PTC) is the most common type of endocrine cancer, with an increasing incidence worldwide. The treatment of PTC is currently the subject of clinical controversy, making it critically important to identify molecular markers that would help improve the risk stratification...

Full description

Bibliographic Details
Main Authors:	Lidija Todorović, Boban Stanojević
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-01-01
Series:	Biomolecules & Biomedicine
Subjects:	Papillary thyroid cancer PTC VHL biomarker risk stratification tumor suppressor
Online Access:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/7850

Similar Items

Experimental study on changes in metabolic mechanism of papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis
by: Danyang Sun, et al.
Published: (2023-10-01)

Long-term outcomes of follicular variant vs classic papillary thyroid carcinoma
by: Lauren E Henke, et al.
Published: (2018-11-01)

Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics
by: Todorović Lidija, et al.
Published: (2020-01-01)

Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma
by: Elisa eMenicali, et al.
Published: (2012-05-01)

Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma
by: Fatemeh Khatami, et al.
Published: (2019-10-01)

Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022
by: Dominika Januś, et al.
Published: (2023-05-01)

RET/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma (PTC)
by: Cristina eRomei, et al.
Published: (2012-04-01)

Dual malignancy in adolescence: A rare case report of metachronous papillary carcinoma of thyroid following dysgerminoma of ovary
by: Suvadip Chakrabarti, et al.
Published: (2016-01-01)

Latest evidence of microwave ablation for papillary thyroid microcarcinoma compared with surgery: A systematic review and meta-analysis
by: Jie Feng, et al.
Published: (2023-02-01)

The mTOR Kinase Inhibitor CZ415 Inhibits Human Papillary Thyroid Carcinoma Cell Growth
by: Xiaobin Li, et al.
Published: (2018-03-01)

TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma
by: Xilin Nie, et al.
Published: (2023-01-01)

Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma
by: Atakan Sezer, et al.
Published: (2017-05-01)

Preoperative risk stratification for patients with ≤ 1 cm papillary thyroid carcinomas based on preoperative blood inflammatory markers: construction of a dynamic predictive model
by: Lingqian Zhao, et al.
Published: (2023-12-01)

Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma
by: Daniel John, et al.
Published: (2023-02-01)

Cribriform morular variant of papillary thyroid carcinoma: Cytomorphology, differential diagnosis and diagnostic implications in patients with adenomatous polyposis coli
by: Amarathunga AH Priyani, et al.
Published: (2016-01-01)

Editorial: Predictors for aggressiveness of papillary thyroid carcinoma
by: Emese Mezosi
Published: (2024-01-01)

Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases
by: Zhuyao Li, et al.
Published: (2023-09-01)

Rethinking the role of oncogenes in papillary thyroid cancer initiation
by: Mario eVitale
Published: (2012-06-01)

Rare Columnar Cell Variant Papillary Thyroid Carcinoma with Metastasis to Pancreas and Lungs at Initial Presentation: A Case Report and Review of Literature
by: Albert Gjeluci, et al.
Published: (2023-01-01)

Pregnancy Outcome in a Thyroid Cancer Survivor
by: Lubna Riaz Dar, et al.
Published: (2019-12-01)

Thoughtful Response on “MRI-based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma” [Letter]
by: Panjaitan NSD, et al.
Published: (2023-01-01)

Prognostic value of long non-coding RNA BLACAT1 in patients with papillary thyroid carcinoma
by: Denghui Liao, et al.
Published: (2018-03-01)

Thoughtful Response on “MRI-Based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma” [Response to Letter]
by: Zheng T, et al.
Published: (2023-02-01)

Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis
by: Bei Qian, et al.
Published: (2022-08-01)

BRAF<sup>V600E</sup> status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China
by: Zheng Xiangqian, et al.
Published: (2012-06-01)

The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature
by: Elham Amjad, et al.
Published: (2024-03-01)

Genotypes of Papillary Thyroid Carcinoma With High Lateral Neck Metastasis in Chinese Population
by: Wei Guo, et al.
Published: (2022-07-01)

Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer
by: Hui-Min Zhang, et al.
Published: (2022-10-01)

Loss of Von Hippel–Lindau (<i>VHL</i>) Tumor Suppressor Gene Function: <i>VHL</i>–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)
by: Hyunho Kim, et al.
Published: (2021-09-01)

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
by: Wei Liu, et al.
Published: (2023-09-01)

Meta-analysis of the effect and clinical significance of Delphian lymph node metastasis in papillary thyroid cancer
by: Yan Chen, et al.
Published: (2024-01-01)

Regulatory role of PTEN and microRNA-141 in papillary thyroid cancer
by: Xianfeng Zhong, et al.
Published: (2020-01-01)

The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
by: Jialin Zhu, et al.
Published: (2019-07-01)

STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
by: Weiman He, et al.
Published: (2023-02-01)

Screening of pharmacogenetic variants associated with drug sensitivity in patients with papillary thyroid carcinoma using next generation sequencing
by: Zora Hammoudeh, et al.
Published: (2017-07-01)

Thyroid Langerhans cell histiocytosis concurrent with papillary thyroid carcinoma: A case report and literature review
by: Bin Mi, et al.
Published: (2023-01-01)

Predictive Factors of Recurrence of Papillary Thyroid Microcarcinomas: Analysis of 2,538 Patients
by: Andre de Ywata Carvalho, et al.
Published: (2021-02-01)

Ultrasonographic imaging of papillary thyroid carcinoma variants
by: Jung Hee Shin
Published: (2017-04-01)

A Clinical Predictive Model of Central Lymph Node Metastases in Papillary Thyroid Carcinoma
by: Zipeng Wang, et al.
Published: (2022-06-01)

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer
by: Steven Craig, et al.
Published: (2023-09-01)